Clusterin is increased in morphologically normal cardiomyocytes in lymphocytic myocarditis

Myocarditis is an inflammatory disease of the heart that is most commonly caused by a viral infection of the heart. Infections with cardiotropic viruses result in lymphocytic myocarditis (LM), characterized by infiltration in majority of lymphocytes into the heart, that can be accompanied by cardiomyocyte death, through virulence and/or the ensuing immune response.1 The pathological findings in autopsied hearts of LM patients are commonly subtle, with a patchy lymphocytic infiltrate and most often limited myocyte necrosis,2 and myocardium that has an overall normal morphological appearance. Knowledge regarding whether and how the viable morphologically normal myocardium is affected in LM is limited. We previously observed an increased presence of the stress response protein clusterin in the hearts of acute myocardial infarction patients.3 Herein, clusterin was not only present in necrotic cardiomyocytes but also in viable morphologically normal cardiomyocytes in the noninfarcted myocardium. Clusterin is a highly conserved glycoprotein found in most mammalian tissues and body fluids and has many biological functions, including chaperonelike functions,4 complement inhibition5 and apoptosis regulation.6 Moreover, cardiomyocytes were shown to express clusterin in response to ischemia and hypertrophic stimuli. Notably, the expression of clusterin was shown before in the hearts of mice with myosininduced autoimmune myocarditis.7 The aim of this study was to analyse the presence of clusterin in the hearts of LM patients with a special focus on the morphologically normal myocardium, and in the heart in time after during Coxsackievirus B3 (CVB3)induced myocarditis in mice.

[1]  H. Niessen,et al.  Electrocardiographic changes are strongly correlated with the extent of cardiac inflammation in mice with Coxsackievirus B3-induced viral myocarditis. , 2021, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[2]  A. Marzullo,et al.  When is myocarditis indeed the cause of death? , 2018, Forensic science international.

[3]  U. Eriksson,et al.  The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[4]  J. Nyengaard,et al.  Quantitative diagnosis of lymphocytic myocarditis in forensic medicine. , 2014, Forensic science international.

[5]  A. Blandino,et al.  Forensic grading of myocarditis: an experimental contribution to the distinction between lethal myocarditis and incidental myocarditis. , 2012, Forensic science international.

[6]  D. Boothman,et al.  CRM1 Protein-mediated Regulation of Nuclear Clusterin (nCLU), an Ionizing Radiation-stimulated, Bax-dependent Pro-death Factor* , 2011, The Journal of Biological Chemistry.

[7]  Dong-hun Kim,et al.  Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3β signaling pathway , 2011, Experimental & Molecular Medicine.

[8]  L. Margaritis,et al.  Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex , 2009, Clinical Cancer Research.

[9]  C. Visser,et al.  Clusterin: a protective mediator for ischemic cardiomyocytes? , 2005, American journal of physiology. Heart and circulatory physiology.

[10]  B. Aronow,et al.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. , 2000, The Journal of clinical investigation.

[11]  G. Nelsestuen,et al.  Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization. , 1997, Biochemistry.

[12]  H. Rockman,et al.  Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury. , 1996, The American journal of pathology.